Cancer/Tumor Profiling Market by (Technology (Immunoassay, NGS, PCR, In-Situ Hybridization, Microarray), Cancer Type (Breast, Lung, Colorectal, Prostate, Melanoma)), Biomarker Type (Genomic, Protein), Application, Region - Global Forecast to 2025

8300
Present Value (M$)
2020
13900
Forecast Value (M$)
2025
10.9%
CAGR (%)

The global cancer/tumor profiling market size is projected to reach USD 13.9 billion by 2025 from USD 8.3 billion in 2020, at a CAGR of 10.9% during the forecast period.

Main companies

  • Illumina
  • Inc. (US)
  • QIAGEN N.V. (Germany)
  • NeoGenomics Laboratories
  • Inc. (US)
  • HTG Molecular Diagnostics
  • Inc. (US)
  • Genomic Health Inc. (US)
  • Caris Life Sciences (US)
  • Helomics Corporation (US)
  • NanoString Technologies
  • Inc. (US)
  • Sysmex Corporation (Japan)
  • Ribomed Biotechnologies
  • Inc. (US)
  • Guardant Health
  • Inc. (US)
  • Foundation Medicine (US) Roche Diagnostics (Switzerland)
  • (US)
  • GenScript Biotech Corporation (China)
  • Tempus Labs (US)
  • Boreal Genomics Inc (Canada)
  • Perthera (US)
  • Agendia (US)
  • Omniseq(US)
  • Histogene X (Belgium).